KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Asset Utilization Ratio (2021 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.52 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 25.64% year-over-year to 0.52, compared with a TTM value of 0.52 through Sep 2025, up 25.64%, and an annual FY2024 reading of 0.43, up 24.24% over the prior year.
  • Asset Utilization Ratio was 0.52 for Q3 2025 at Aurinia Pharmaceuticals, roughly flat from 0.52 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.52 in Q2 2025 and bottomed at 0.06 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.34, with a median of 0.32 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio surged 346.28% in 2022, then rose 8.25% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.1 in 2021, then soared by 176.82% to 0.28 in 2022, then rose by 13.86% to 0.32 in 2023, then surged by 34.34% to 0.43 in 2024, then grew by 20.72% to 0.52 in 2025.
  • Business Quant data shows Asset Utilization Ratio for AUPH at 0.52 in Q3 2025, 0.52 in Q2 2025, and 0.47 in Q1 2025.